Suicide Genes
- 1 January 2002
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectivesJournal of Cellular Physiology, 2001
- Genetic Prodrug Activation Therapy for Breast Cancer: A Phase I Clinical Trial oferbB-2–Directed Suicide Gene ExpressionJournal of Clinical Oncology, 1999
- Re: Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene Therapies RESPONSEJNCI Journal of the National Cancer Institute, 1999
- A Novel Three-Pronged Approach to Kill Cancer Cells Selectively: Concomitant Viral, Double Suicide Gene, and RadiotherapyHuman Gene Therapy, 1998
- In VivoGene Therapy of Cancer withE. coliPurine Nucleoside PhosphorylaseHuman Gene Therapy, 1997
- The expression of bacterial nitroreductase in transgenic mice results in specific cell killing by the prodrug CB1954Gene Therapy, 1997
- Viral vector transduction of the human deoxycytidine kinase cDNA sensitizes glioma cells to the cytotoxic effects of cytosine arabinoside in vitro and in vivoNature Medicine, 1996
- Retrovirally TransducedEscherichia coli gptGenes Combine Selectability with Chemosensitivity Capable of Mediating Tumor EradicationHuman Gene Therapy, 1993
- Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: a negative selection system.Proceedings of the National Academy of Sciences, 1992
- Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase TransgeneHuman Gene Therapy, 1990